Question · Q4 2025
Jeff Schmitt asked about the drivers behind the healthcare business's tough organic growth quarter, its lack of momentum, and an update on the Elevance relationship regarding DomaniRx onboarding.
Answer
Bill Stone, Chairman and CEO, explained that healthcare is a long-term, lumpy business, noting large license sales in the prior Q4 and early Q1 2026. He highlighted new technology like Amisys and DomaniRx, acknowledging lower growth but healthy EBITDA margins. Regarding Elevance, Mr. Stone stated DomaniRx is ready, but acknowledged the challenges of long-standing relationships and the loss of the original sponsor, while still seeing potential.
Ask follow-up questions
Fintool can predict
SSNC's earnings beat/miss a week before the call
